# Long Term Safety Trial of z102 and Prednisone in Patients With Moderate to Severe Rheumatoid Arthritis

> **NCT01612377** · PHASE2 · TERMINATED · sponsor: **Zalicus** · enrollment: 18 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Prednisolone-Dipyridamole
- **DRUG:** Prednisone
- **DRUG:** prednisone

## Key facts

- **NCT ID:** NCT01612377
- **Lead sponsor:** Zalicus
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-03
- **Primary completion:** 2013-07
- **Final completion:** 2013-09
- **Target enrollment:** 18 (ACTUAL)
- **Why stopped:** missed endpoint of meaningful clinical benefit, compared to prednisolone 2.7mg
- **Last updated:** 2012-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01612377

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01612377, "Long Term Safety Trial of z102 and Prednisone in Patients With Moderate to Severe Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01612377. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*